SCHEMBL9348499

SCHEMBL9348499

CCC(CC)(c1cc(CBr)cc(-c2ccc(Cl)cc2)c1)P(=O)(O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN5 P54829 9/20 0.41
▸ ACP3 P15309 1/20 0.34
▸ GRIN2D O15399 1/20 0.33
▸ GRIN3B O60391 1/20 0.33
▸ GRIN1 Q05586 1/20 0.33
▸ GRIN2A Q12879 1/20 0.33
▸ GRIN2B Q13224 1/20 0.33
▸ GRIN2C Q14957 1/20 0.33
▸ GRIN3A Q8TCU5 1/20 0.33
▸ SHMT1 P34896 1/20 0.32
▸ SHMT2 P34897 1/20 0.32
▸ GGPS1 O95749 2/20 0.32
▸ MMP1 P03956 1/20 0.32
▸ MMP2 P08253 1/20 0.32
▸ MMP3 P08254 1/20 0.32
▸ MMP7 P09237 1/20 0.32
▸ MMP9 P14780 1/20 0.32
▸ MMP8 P22894 1/20 0.32
▸ MMP13 P45452 1/20 0.32
▸ MMP14 P50281 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9343945 0.87 PTPN5 (0.46) PTPN5GGPS1PTPN1FDPS
SCHEMBL1354398 0.75 MEN1 (0.42) PTPN5ACP3GGPS1
SCHEMBL8992169 0.75 PTPN5 (0.40) PTPN5ACP3GGPS1PTPN1
SCHEMBL9344792 0.74 GRIN2D (0.46) PTPN5GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL9445936 0.74 PGK1 (0.45) PTPN5ACP3GGPS1PTPN1FDPS
SCHEMBL9445920 0.73 PTPN1 (0.39) PTPN1FDPS
SCHEMBL5859053 0.72 PTPN5 (0.46) PTPN5GGPS1PTPN1
SCHEMBL23908217 0.70 PGK1 (0.43) PTPN5PTPN1FDPS
SCHEMBL1338013 0.67 PGK1 (0.44) PTPN5ACP3GGPS1
SCHEMBL7870277 0.66 PGK1 (0.44) PTPN5PTPN1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5321016-A Epliepsy, central nervous system disorders SANDOZ PHARMACEUTICALS CORP. (US) 1994-06-14 — — US disclosed
US-5162311-A Treating epilepsy, psychiatric disorders SANDOZ PHARMACEUTICALS CORP. (US) 1992-11-10 — — US disclosed
Send feedback